{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:13:34Z","timestamp":1793106814293,"version":"4.5.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Adrenocortical carcinoma (ACC) is a rare endocrine malignancy of the adrenal gland with an unfavorable prognosis. It is rare in the pediatric population, with an incidence of 0.2-0.3 patients per million in patients under 20 years old. It is primarily associated with Li-Fraumeni and Beckwith-Wiedemann tumor predisposition syndromes in children. The incidence of pediatric ACC is 10-15fold higher in southern Brazil due to a higher prevalence of <jats:italic>TP53<\/jats:italic> mutation associated with Li-Fraumeni syndrome in that population. Current treatment protocols are derived from adult ACC and consist of surgery and\/or chemotherapy with etoposide, doxorubicin, and cisplatin (EDP) with mitotane. Limited research has been reported on other treatment modalities for pediatric ACC, including mitotane, pembrolizumab, cabozantinib, and chimeric antigen receptor autologous cell (CAR-T) therapy.<\/jats:p>","DOI":"10.3389\/fendo.2022.961650","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T04:49:22Z","timestamp":1667191762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Pediatric adrenocortical carcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Maran","family":"Ilanchezhian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Grace","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Glod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlyne M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte C.","family":"Widemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosandra N.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydira","family":"Del Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2013.02.017","article-title":"Predictors of survival in pediatric adrenocortical carcinoma: a surveillance, epidemiology, and end results (SEER) program study","volume":"48","author":"McAteer","year":"2013","journal-title":"J Pediatr Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W","article-title":"Childhood cancer","volume":"75","author":"Miller","year":"1995","journal-title":"Cancer."},{"key":"B3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.sempedsurg.2005.11.008","article-title":"Malignant adrenal tumors","author":"Rescorla","year":"2006","journal-title":"Semin Pediatr Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0022-5347(05)64023-2","article-title":"Adrenocortical carcinoma: diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(93)90341-H","article-title":"Adrenocortical carcinoma in children: clinical aspects and prognosis","volume":"28","author":"Sabbaga","year":"1993","journal-title":"J Pediatr Surgery"},{"key":"B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2011.10.019","article-title":"Molecular epidemiology of adrenocortical tumors in southern Brazil","volume":"351","author":"Cust\u00f3dio","year":"2012","journal-title":"Mol Cell endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00023","article-title":"Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors","volume":"6","author":"Lalli","year":"2015","journal-title":"Front Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-25905-1_9","article-title":"Diseases predisposing to adrenocortical malignancy (Li\u2013fraumeni syndrome, beckwith\u2013wiedemann syndrome, and Carney complex)","volume":"111","author":"Jouinot","year":"2019","journal-title":"Genet Endocrine Dis Syndromes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.554388","article-title":"Clinical, genetic, and prognostic features of adrenocortical tumors in children: A 10-year single-center experience","volume":"10","author":"Miele","year":"2020","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2001.22280","article-title":"Adrenocortical tumors in children","volume":"36","author":"Ciftci","year":"2001","journal-title":"J Pediatr surgery"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: A report from the international pediatric adrenocortical tumor registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"101448","DOI":"10.1016\/j.beem.2020.101448","article-title":"Pediatric adrenocortical tumours","volume":"34","author":"Pinto","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.7.2027","article-title":"Childhood adrenocortical tumors","volume":"82","author":"Sandrini","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000488855","article-title":"Adrenocortical carcinoma in children: A clinicopathological analysis of 41 patients at the Mayo clinic from 1950 to 2017","volume":"90","author":"Gupta","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26368","article-title":"Outcome and prognostic factors in high-risk childhood adrenocortical carcinomas: a report from the European cooperative study group on pediatric rare tumors (EXPeRT)","volume":"64","author":"Cecchetto","year":"2017","journal-title":"Pediatr Blood cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.8.606","article-title":"Multiple primary cancers in families with Li-fraumeni syndrome","volume":"90","author":"Hisada","year":"1998","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome","volume":"71","author":"Li","year":"1969","journal-title":"Ann Internal Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.09.010","article-title":"Towards an understanding of the role of p53 in adrenocortical carcinogenesis","volume":"351","author":"Wasserman","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/358015a0","article-title":"p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.22.1707","article-title":"High frequency of germline p53 mutations in childhood adrenocortical cancer","volume":"86","author":"Wagner","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1982","article-title":"TP53 germline mutations in adult patients with adrenocortical carcinoma","volume":"97","author":"Herrmann","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1200\/JCO.2012.46.3711","article-title":"Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors","volume":"31","author":"Cust\u00f3dio","year":"2013","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1086\/302575","article-title":"Are there low-penetrance TP53 alleles? evidence from childhood adrenocortical tumors","volume":"65","author":"Varley","year":"1999","journal-title":"Am J Hum Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.030551","article-title":"Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation","volume":"43","author":"Figueiredo","year":"2006","journal-title":"J Med Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.10.7957","article-title":"An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors","volume":"86","author":"Latronico","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B29","article-title":"Adrenocortical tumors and hyperplasias in childhood\u2013etiology, genetics, clinical presentation and therapy","volume":"4","author":"Sutter","year":"2006","journal-title":"Pediatr Endocrinol Rev"},{"key":"B30","volume-title":"Beckwith-wiedemann syndrome","author":"Shuman","year":"2016"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg067","article-title":"Beckwith\u2013wiedemann syndrome demonstrates a role for epigenetic control of normal development","volume":"12","author":"Weksberg","year":"2003","journal-title":"Hum Mol Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021069","article-title":"The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors","volume":"87","author":"Koch","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ng1410","article-title":"Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and beckwith-wiedemann syndrome","volume":"36","author":"Sparago","year":"2004","journal-title":"Nat Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.2.6.678","article-title":"Mechanisms by which IGF-I may promote cancer","volume":"2","author":"Grimberg","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2005.05.010","article-title":"Fetal adrenal development: insight gained from adrenal tumors","volume":"16","author":"Coulter","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26432","article-title":"Management of adrenal masses in patients with beckwith-wiedemann syndrome","volume":"64","author":"MacFarland","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e103744","DOI":"10.1371\/journal.pone.0103744","article-title":"IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma","volume":"9","author":"Guillaud-Bataille","year":"2014","journal-title":"PLos One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/jcem.75.1.1352309","article-title":"Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1","volume":"75","author":"Skogseid","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0526","article-title":"Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature","volume":"8","author":"Wang","year":"2019","journal-title":"Endocr Connect"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.07.039","article-title":"Calculation of risk of colorectal and endometrial cancer among patients with lynch syndrome","volume":"137","author":"Stoffel","year":"2009","journal-title":"Gastroenterology."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.0988","article-title":"Adrenocortical carcinoma is a lynch syndrome-associated cancer","volume":"31","author":"Raymond","year":"2013","journal-title":"J Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-4-22","article-title":"Familial adenomatous polyposis","volume":"4","author":"Half","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"bcr","DOI":"10.1136\/bcr-2018-226799","article-title":"Incidentally detected adrenocortical carcinoma in familial adenomatous polyposis: an unusual presentation of a hereditary cancer syndrome","volume":"2018","author":"Agarwal","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001008","article-title":"Characteristics of adrenal masses in familial adenomatous polyposis","volume":"61","author":"Shiroky","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"B46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","article-title":"NF1 gene and neurofibromatosis 1","volume":"151","author":"Rasmussen","year":"2000","journal-title":"Am J Epidemiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa032","article-title":"Abdominal neoplastic manifestations of neurofibromatosis type 1","volume":"2","author":"Dare","year":"2020","journal-title":"Neurooncol Adv"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.11.003","article-title":"Race\/ethnicity, but not income, are associated with increased odds of shellfish allergy","volume":"9","author":"Abrams","year":"2021","journal-title":"J Allergy Clin Immunol: In Practice"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-14-0074","article-title":"Adrenal cancer in neurofibromatosis type 1: case report and DNA analysis","volume":"2014","author":"Menon","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.12.4.613","article-title":"Adrenocortical carcinoma in a patient with neurofibromatosis type 1: A case report","volume":"12","author":"Najafi-Semnani","year":"2021","journal-title":"Caspian J Intern Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.281","article-title":"Large Invasive adrenal cortical carcinoma in a patient with neurofibromatosis type I","volume":"5","author":"Sandoval","year":"2021","journal-title":"J Endocrine Society"},{"key":"B52","article-title":"Carney Complex","volume-title":"GeneReviews\u00ae","author":"Stratakis","year":"2018"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2321","article-title":"Carney Complex with adrenal cortical carcinoma","volume":"97","author":"Morin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2244","article-title":"A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer","volume":"97","author":"Anselmo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3327","article-title":"Adrenocortical cancer in Carney complex: a paradigm of endocrine tumor progression or an association of genetic predisposing factors","volume":"97","author":"Bertherat","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2374","article-title":"Targeting estrogen receptor-alpha reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment","volume":"97","author":"Sirianni","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.3390\/cancers13215266","article-title":"Adrenocortical carcinoma in childhood: A systematic review","volume":"13","author":"Riedmeier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2639","article-title":"Adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.95699","article-title":"Childhood adrenocortical carcinoma: Case report and review","volume":"16","author":"Gundgurthi","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.01.031","article-title":"Childhood adrenocortical tumours","volume":"40","author":"Ribeiro","year":"2004","journal-title":"Eur J Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1304627","article-title":"Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial","volume":"224","author":"Hubertus","year":"2012","journal-title":"Klin Padiatr"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02871","article-title":"Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: The children's oncology group ARAR0332 protocol","volume":"39","author":"Rodriguez-Galindo","year":"2021","journal-title":"J Clin Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0022-5347(05)65881-8","article-title":"Rupture of adrenal carcinoma after biopsy","volume":"166","author":"Kardar","year":"2001","journal-title":"J Urol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.surg.2005.09.012","article-title":"Laparoscopic resection of adrenal cortical carcinoma: a cautionary note","volume":"138","author":"Gonzalez","year":"2005","journal-title":"Surgery."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000540","article-title":"Pediatric adrenocortical tumor\u2013review and management update","volume":"27","author":"Brondani","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000212965.52759.1c","article-title":"Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: Mitotane monitoring and tumor regression","volume":"28","author":"Zancanella","year":"2006","journal-title":"J Pediatr Hematol\/Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1327579","article-title":"Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial","volume":"224","author":"Redlich","year":"2012","journal-title":"Klin Padiatr"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30671-0","article-title":"Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1\u20132 trial","volume":"21","author":"Geoerger","year":"2020","journal-title":"Lancet Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz318","article-title":"Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib","volume":"105","author":"Kroiss","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.10010","article-title":"Phase 2 trial of cabozantinib in children and young adults with refractory sarcomas, wilms tumor, and rare tumors: Children's oncology group study (ADVL1622)","volume":"39","author":"Akshintala","year":"2021","journal-title":"J Clin Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0432","article-title":"CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors","volume":"25","author":"Majzner","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3109\/08880019809018314","article-title":"Adrenal cortical tumors in childhood","volume":"15","author":"Driver","year":"1998","journal-title":"Pediatr Hematol Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.09.040","article-title":"Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults","volume":"351","author":"Faria","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/cancers12030689","article-title":"Cancer-testis antigen FATE1 expression in adrenocortical tumors is associated with a pervasive autoimmune response and is a marker of malignancy in adult, but not children, ACC","volume":"12","author":"Doghman-Bouguerra","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2019.08.009","article-title":"Contemporary preclinical human models of adrenocortical carcinoma","volume":"8","author":"Pinto","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63846-1","article-title":"Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis","volume":"162","author":"Giordano","year":"2003","journal-title":"Am J Pathol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/cancers12051218","article-title":"Past, present and future of epigenetics in adrenocortical carcinoma","volume":"12","author":"Ettaieb","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1456","article-title":"Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma","volume":"94","author":"Barlaskar","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70081-1","article-title":"Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study","volume":"16","author":"Fassnacht","year":"2015","journal-title":"Lancet Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-014-0182-1","article-title":"The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent\/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial","volume":"5","author":"Lerario","year":"2014","journal-title":"Horm Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00197","article-title":"Therapeutic targets for adrenocortical carcinoma in the genomics era","volume":"2","author":"Mohan","year":"2018","journal-title":"J Endocr Soc"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055743","article-title":"Silencing mutated \u03b2-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R","volume":"8","author":"Gaujoux","year":"2013","journal-title":"PLos One"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5513","article-title":"Inhibition of the tcf\/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis","volume":"6","author":"Leal","year":"2015","journal-title":"Oncotarget."},{"key":"B87","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drudis.2021.07.007","article-title":"Advances in targeting the WNT\/\u03b2-catenin signaling pathway in cancer","volume":"27","author":"Chatterjee","year":"2022","journal-title":"Drug Discovery Today"},{"key":"B88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","article-title":"Targeting the wnt\/beta-catenin pathway in cancer: Update on effectors and inhibitors","volume":"62","author":"Krishnamurthy","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B91","article-title":"mRNA and microRNA expression patterns in adrenocortical cancer","volume":"1","author":"Zsippai","year":"2011","journal-title":"Am J Cancer Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2765","article-title":"[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma","volume":"97","author":"Hahner","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz091","article-title":"Treatment with 90Y\/177Lu-DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors","volume":"105","author":"Grisanti","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.961650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T04:49:30Z","timestamp":1667191770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.961650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":93,"alternative-id":["10.3389\/fendo.2022.961650"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.961650","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"article-number":"961650"}}